A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy
- 12 September 2012
- journal article
- Published by Elsevier BV in Biomaterials
- Vol. 33 (34), 8893-8905
- https://doi.org/10.1016/j.biomaterials.2012.08.057
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Lipoprotein-Inspired Nanoparticles for Cancer TheranosticsAccounts of Chemical Research, 2011
- Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrierJournal of Drug Targeting, 2009
- Proto-oncogene FBI-1 Represses Transcription of p21CIP1 by Inhibition of Transcription Activation by p53 and Sp1Online Journal of Public Health Informatics, 2009
- Proto-oncogene FBI-1 (Pokemon/ZBTB7A) Represses Transcription of the Tumor Suppressor Rb Gene via Binding Competition with Sp1 and Recruitment of Co-repressorsOnline Journal of Public Health Informatics, 2008
- Evaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxelAnti-Cancer Drugs, 2008
- Mechanisms and optimization of in vivo delivery of lipophilic siRNAsNature Biotechnology, 2007
- Interfering with disease: a progress report on siRNA-based therapeuticsNature Reviews Drug Discovery, 2007
- Potent and persistent in vivo anti-HBV activity of chemically modified siRNAsNature Biotechnology, 2005
- RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivoGene Therapy, 2004
- SR‐BI and HDL Cholesteryl Ester MetabolismEndocrine Research, 2004